Ocuphire Pharma Stock Price Prediction
| OCUP Stock | USD 1.99 0.14 7.57% |
Oversold Vs Overbought
26
Oversold | Overbought |
Ocuphire Pharma stock price prediction is an act of determining the future value of Ocuphire Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Ocuphire Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Ocuphire Pharma and does not consider all of the tangible or intangible factors available from Ocuphire Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with Ocuphire Pharma, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Ocuphire Pharma's stock price prediction:EPS Estimate Next Quarter (0.10) | EPS Estimate Current Year (0.31) | EPS Estimate Next Year 1.03 | Wall Street Target Price 19.2 | EPS Estimate Current Quarter (0.05) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Ocuphire Pharma based on different types of headlines from major news networks to social media. The Ocuphire stock price prediction module provides an analysis of price elasticity to changes in media outlook on Ocuphire Pharma over a specific investment horizon. Using Ocuphire Pharma hype-based prediction, you can estimate the value of Ocuphire Pharma from the perspective of Ocuphire Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Ocuphire Pharma using Ocuphire Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Ocuphire using crowd psychology based on the activity and movement of Ocuphire Pharma's stock price.
Ocuphire Pharma Implied Volatility | 0.0 |
Ocuphire Pharma's implied volatility exposes the market's sentiment of Ocuphire Pharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Ocuphire Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Ocuphire Pharma stock will not fluctuate a lot when Ocuphire Pharma's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Ocuphire Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Ocuphire Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Ocuphire because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ocuphire Pharma after-hype prediction price | USD 2.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ocuphire |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ocuphire Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ocuphire Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Ocuphire Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ocuphire Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ocuphire Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ocuphire Pharma Estimiated After-Hype Price Volatility
In the context of predicting Ocuphire Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ocuphire Pharma's historical news coverage. Ocuphire Pharma's after-hype downside and upside margins for the prediction period are 0.10 and 6.53, respectively. We have considered Ocuphire Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ocuphire Pharma is moderately volatile at this time. Analysis and calculation of next after-hype price of Ocuphire Pharma is based on 3 months time horizon.
Ocuphire Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Ocuphire Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ocuphire Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ocuphire Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 4.53 | 0.01 | 3.04 | 10 Events / Month | 1 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.99 | 2.00 | 0.50 |
|
Ocuphire Pharma Hype Timeline
Ocuphire Pharma is now traded for 1.99. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 3.04. Ocuphire is anticipated to increase in value after the next headline, with the price projected to jump to 2.0 or above. The average volatility of media hype impact on the company the price is over 100%. The price gain on the next news is projected to be 0.5%, whereas the daily expected return is now at -0.31%. The volatility of related hype on Ocuphire Pharma is about 46.26%, with the expected price after the next announcement by competition of 5.03. The company reported the previous year's revenue of 19.05 M. Net Loss for the year was (9.99 M) with loss before overhead, payroll, taxes, and interest of (14.58 M). Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Ocuphire Pharma Basic Forecasting Models to cross-verify your projections.Ocuphire Pharma Related Hype Analysis
Having access to credible news sources related to Ocuphire Pharma's direct competition is more important than ever and may enhance your ability to predict Ocuphire Pharma's future price movements. Getting to know how Ocuphire Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ocuphire Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VRTHF | Veritas Pharma | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SGBI | Sangui Biotech International | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RAPH | Raphael Pharmaceutical | 39.17 | 23 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GSAC | GelStat Corp | 0.00 | 0 per month | 9.79 | 0.03 | 25.00 | (25.00) | 58.33 |
Ocuphire Pharma Additional Predictive Modules
Most predictive techniques to examine Ocuphire price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ocuphire using various technical indicators. When you analyze Ocuphire charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ocuphire Pharma Predictive Indicators
The successful prediction of Ocuphire Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ocuphire Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ocuphire Pharma based on analysis of Ocuphire Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ocuphire Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ocuphire Pharma's related companies. | 2023 | 2024 (projected) | Payables Turnover | 0.002787 | 0.005371 | Days Of Inventory On Hand | 0.1 | 0.0997 |
Story Coverage note for Ocuphire Pharma
The number of cover stories for Ocuphire Pharma depends on current market conditions and Ocuphire Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ocuphire Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ocuphire Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Ocuphire Pharma Short Properties
Ocuphire Pharma's future price predictability will typically decrease when Ocuphire Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ocuphire Pharma often depends not only on the future outlook of the potential Ocuphire Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ocuphire Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.6 M | |
| Cash And Short Term Investments | 50.5 M |
Check out Ocuphire Pharma Basic Forecasting Models to cross-verify your projections. To learn how to invest in Ocuphire Stock, please use our How to Invest in Ocuphire Pharma guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Ocuphire Stock analysis
When running Ocuphire Pharma's price analysis, check to measure Ocuphire Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocuphire Pharma is operating at the current time. Most of Ocuphire Pharma's value examination focuses on studying past and present price action to predict the probability of Ocuphire Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocuphire Pharma's price. Additionally, you may evaluate how the addition of Ocuphire Pharma to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Ocuphire Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocuphire Pharma. If investors know Ocuphire will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocuphire Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.882 | Quarterly Revenue Growth (0.96) | Return On Assets (0.13) | Return On Equity (0.21) |
The market value of Ocuphire Pharma is measured differently than its book value, which is the value of Ocuphire that is recorded on the company's balance sheet. Investors also form their own opinion of Ocuphire Pharma's value that differs from its market value or its book value, called intrinsic value, which is Ocuphire Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocuphire Pharma's market value can be influenced by many factors that don't directly affect Ocuphire Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocuphire Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocuphire Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocuphire Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.